Teva Releases Q3 2026 Aide Memoire
Teva Pharmaceutical Industries Ltd. announced the availability of its Q3 2026 Aide Memoire, a document compiling prior public information to assist investors ahead of the company's upcoming third quarter earnings report, scheduled for November 3, 2026. The release also included a standard caution on forward-looking statements and outlined risks inh…